N/A
N=19
The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study
Pain · Obesity · Surgery
Bottom Line
View on ClinicalTrials.gov: NCT01075087 ↗Enrolled (actual)
19
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcome: Primary: Quality of Recovery 40 Score — 170; 175.5 units on scale 40 (low) - 200 (high) — p=.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Placebo (Drug); (study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side. (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Jul 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Recovery 40 Score |
170; 175.5 | .05 |
| SECONDARY 24 Hour Total Opioid Consumption. |
13; 7.5 | — |
Summary
The use of preoperative TAP block in laparoscopic bariatric surgery can improve the postoperative pain and quality of recovery in patients undergoing these procedures.
Eligibility Criteria
Inclusion Criteria
- Age: 18-65 years
- BMI >35 Kg/m2
- Surgery: laparoscopic gastric bypass surgery
- ASA status: I, II and III
- Fluent in English
Exclusion Criteria
- History of allergy to local anesthetics
- Chronic opioid use
- Pregnant patients
- Patients who remained intubated after surgery
Drop-out criteria:
Patient or surgeon request Complications related to the procedure or conversion to open route Patient requiring mechanical ventilation after surgery
Data sourced from ClinicalTrials.gov (NCT01075087). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.